uridine triphosphate has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnett, TR; Guneri, D; Hajjawi, MOR; Orriss, IR; Patel, JJ; Shaw, K | 1 |
| Bilbe, G; Bowler, WB; Dixon, CJ; Gallagher, JA; Littlewood-Evans, A | 1 |
2 other study(ies) available for uridine triphosphate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Activation of the P2Y
Topics: Adenosine Triphosphate; Aging; Animals; Bone Density; Bone Resorption; Mice; Mice, Knockout; Osteoblasts; Osteoclasts; Receptors, Purinergic P2Y2; Uridine Triphosphate | 2017 |
P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption.
Topics: Adenosine Triphosphate; Affinity Labels; Bone Neoplasms; Bone Resorption; Calcium; Cytosol; Giant Cell Tumor of Bone; Humans; In Situ Hybridization; Nickel; Osteoclasts; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Tumor Cells, Cultured; Uridine Triphosphate | 1998 |